🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

AI for Protein Folding deservingly named one of the 10 breakthroughs for 2022 by MIT Technology Review. #SyntheticBiology embodies the Learn/Design/Build/Test flywheel of engineering. Our ultra high throughput Build/Test platform will truly unleash the power of #AI-driven Learn/Design

We are thrilled to see the fantastic response at #KSCancerImmuno22 for our CEO, Xi Chen, presenting on functional decoding of tumor immune repertoire. Thank you to Keystone Symposia for hosting the spectacular event!

Come see our Co-Founder and CEO, Xi Chen, present at #BuiltWithBiology Conference, "What To Do With Limitless Gene Synthesis: T Cell Therapy and Beyond" on Wednesday, April 13 at 12:30pm PDT. builtwithbiology.com/attend/confere…

Come see our CEO and Co-Founder Xi Chen today present ‘What to do with Limitless Gene Synthesis: T Cell Therapy & Beyond’ at 12:30PM PDT at the #BuiltWithBiology conference! (Oakland Room, 3rd Floor)

Our Co-Founder & CEO Xi Chen shared his thoughts with GenomeWeb: "Key values in biotech in the next 10 years will be created by going back and forth between sequences and functional readouts. What we're going to do is remove the speed bumps in between." bit.ly/38sQG4O

We are proud to announce that RootPath’s scientific and technology leaders will present on approaches to #TCell therapy at #SITC22 this November. Learn more here: bit.ly/3rwTKD3 #SITC2022

We’ll be at #SITC22 this week presenting 3 posters on the discovery of #tumor reactive TCRs in various applications of our proprietary platforms: Pathfinder, Interpreter and DisPATCH. More details are available here: bit.ly/3Uvyhav

We are proud to launch RootPath Custom Gene Library in the US, slashing gene synthesis cost by more than half, to as low as $0.04/bp. Let RootPath double your screening throughput with the same budget! Learn more from our official announcement: businesswire.com/news/home/2023…

Did you know? You can save $32K on gene synthesis for a metagenomic mining project that would otherwise cost $63K. In other words, >50% SAVING! Order today: bit.ly/4i4DCk4 #DNA #SynBio

Did you know? Since launching our gene synthesis service in late 2023, we have shipped over 35,000 constructs to customers in the US, China, Singapore, and the European Union — averaging nearly 700 constructs per week. Thanks to our novel synthesis technology, we routinely

Our founder Dr. Xi Chen will be at SynBioBeta 2025 and speaking on the panel “Deconstructing Cellular Diversity: Single‑Cell Sequencing for Drug Discovery & Synthetic Biology,” Thursday, May 8 at 2:30 p.m. Join us to discuss how next-generation gene synthesis technologies and

We welcome the first ever #MegabaseSpark submission, from Ewan McRae: "We’re building a synthetic library of RNA sequence variants to map how mutations reshape RNA folding and function. By encoding thousands of designed variants in synthetic DNA, we aim to uncover design rules

Happy Friday! We got a new #MegabaseSpark submission from Liyuan Liu: This research uses synthetic biology to determine if all 20 canonical amino acids are essential for life. By designing and testing proteins with fewer amino acids in bacteria, we aim to uncover fundamental life